Biological E. Ltd. (BE) has bagged an order valued at over Rs.895 crore for supplying its ComBE Five, a 5-in-1 Liquid Pentavalent Vaccine, to the Union Ministry of Health and Family Welfare.
Announcing this on Monday, the company said that the order, awarded to it under a tender, will be executed over a period of two years.
The Liquid Pentavalent Vaccine, the Biological E. release said, was to be inducted into Government of India’s Universal Immunization Programme. It would provide a boost to Mission Indradhanush, an initiative to empower the Programme and extend full immunization coverage to at least 90 per cent of all children in the country.
ComBE Five has received World Health Organization’s pre-qualification approval. The vaccine consists of Diphtheria, Tetanus, Pertussis, Hib (Haemophilus Influenza Type b) and Hepatitis B. More than 200 million doses of the 5-in-1 vaccine from BE had been administered to children around the world, the company said.
Managing Director Mahima Datla said the BE had supported the UIP right from its inception as a major vaccine manufacturer. For the company, India is the most significant market and this contract will further contribute to the BE’s growth.
As part of its expansion in Telangana, the BE is investing more than Rs.500 crore in building new facilities over a period of three years to augment production capacity for vaccines as well as complex generics.
